Rabbit anti-thymocyte globulin to prevent GVHD

Affiliations

Comment

Alessandro Rambaldi. Lancet Oncol. 2016 Feb.

. 2016 Feb;17(2):124-125.

doi: 10.1016/S1470-2045(15)00516-1. Epub 2015 Dec 24.

¹ Hematology and BMT Unit, Azienda Ospedaliera Papa Giovanni XXIII, 24127 Bergamo, Italy. Electronic address: arambaldi@hpg23.it.

No abstract available

Comment on

Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing haemopoietic cell transplantation from unrelated donors: a randomised, controlled, open-label, phase 3, multicentre trial.
Walker I, Panzarella T, Couban S, Couture F, Devins G, Elemary M, Gallagher G, Kerr H, Kuruvilla J, Lee SJ, Moore J, Nevill T, Popradi G, Roy J, Schultz KR, Szwajcer D, Toze C, Foley R; Canadian Blood and Marrow Transplant Group. Walker I, et al. Lancet Oncol. 2016 Feb;17(2):164-173. doi: 10.1016/S1470-2045(15)00462-3. Epub 2015 Dec 24. Lancet Oncol. 2016. PMID: 26723083 Clinical Trial.